Saturday, 3 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· December 30, 2025

12 investors dish on what 2026 will bring for climate tech

View original at finance.yahoo.com
12 investors dish on what 2026 will bring for climate tech Image Credits:Bryce Durbin / TechCrunch This was supposed to be the year that climate tech died…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Natural gas turbines seeing linear growth; selling all capacity; limited new manufacturing

    80% confidence
  • Private credit and commercial lenders entering with insurance underwriting support

    80% confidence
  • Massive innovation where AI meets physical world

    80% confidence
  • Geothermal is hot on solar's heels for new generation

    80% confidence
  • First off-grid world-scale data center expected

    80% confidence
  • Labor shortage driver for next-gen robotics; national security concerns

    80% confidence
  • Chemfinity achieving domestic metal refining at cost parity with China

    80% confidence
  • Shift from demand to resilience and grid decoupling in data center trends

    80% confidence
  • Unit economics of foundational AI shops will not look good but investors will support through trough

    80% confidence
  • Defense and industrial policy backing dual-use climate tech for cost/supply security

    80% confidence
  • Underground transmission line build-out using robotics to reduce wildfire risk

    80% confidence
  • Thermal energy storage for load shifting in industrial applications ready for scale

    80% confidence
  • Battery recycling subsector to watch for IPOs

    80% confidence
  • Focus shifting from generation to grid execution speed

    80% confidence
  • Robotics not humanoid type; taking over labor-intensive industries: industrial, agriculture, waste, manufacturing

    80% confidence
  • Data centers will become better grid participants through flexibility, load shaping, power quality for faster interconnect

    80% confidence
  • 40-45% of world copper refining is in China, followed by Chile

    80% confidence
  • IRA policy shifts expected but won't stop zero-carbon generation trends

    80% confidence
  • Industrial heat pumps, thermal storage for steam/process heat becoming cheaper than gas boilers

    80% confidence
  • Local governments may challenge hyperscalers for community-aligned solutions and municipal partnerships

    80% confidence
  • Nuclear expected to be IPO/SPAC leaders in 2026

    80% confidence
  • Federal support for critical minerals, battery materials as supply chain security priority

    80% confidence
  • Relectrify deploying 100 MWh cumulative capacity in 2026; cell-level semiconductor control eliminates inverter

    80% confidence
  • PJM grid (Midatlantic to Illinois) and Texas favored for battery deployment

    80% confidence
  • Fusion is still 10+ years from high-capacity grid deployment

    80% confidence
  • AI-driven physical science (Zanskar, Fabric8 Labs) talent pool impressive

    80% confidence
  • ASICs/ASIPs will begin replacing GPUs for AI inference workloads

    80% confidence
  • Distributed power, heat, computation trends emerging

    80% confidence
  • Single gigawatt data center requires tens of thousands of tonnes of copper

    80% confidence
  • Significant investment expected in SAF in 2026

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com